Latest News
MS treatment announcement from PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) makes recommendations to the Australian Government about the medicines for subsidy through the Pharmaceutical Benefits Scheme (PBS).
At an “out-of-session” meeting in September 2020, the Pharmaceutical Benefits Advisory Committee (PBAC...
Australian Government approves PBS listing of Siponimod (brand name Mayzent®) for secondary progressive MS.
Yesterday (25 October, 2020) the Federal Health Minister, the Hon Greg Hunt MP announced the listing of siponimod (Mayzent) for the treatment of secondary progressive MS (SPMS) on the Pharmaceutical Benefits Scheme (PBS), from 1 November, 2020.
The Federal Health Minister’s media release...
#WhyWeCare – National Carers Week 2020
(Pictured: The Veronicas, Lisa & Jess Origliasso, who care for their mum, Colleen.)
Carers make an invaluable contribution to our communities in Australia. This year's National Carers Week, held from 11 to 17 October, will...
MS Australia’s response to Federal Budget 2020-21 – impact on the MS community
Introduction
If we thought last year’s Federal Budget was unusual, coming as it did a month early at the beginning of an election campaign, then this year’s Budget (handed down on Tuesday 6 October), is extra-ordinary!
MS Australia welcomes the Younger People in Residential Aged Care Strategy
MS Australia welcomes the release by the Australian Government of the ...
The new edition of the Atlas of MS is now available!
Did you know that:
- 2.8 million people worldwide have multiple sclerosis (nearly 26,000 in Australia)?
- On average, a person is diagnosed with MS at 32 years of age?
- Or that every 5 minutes, someone around the world is diagnosed with MS?
The Atlas of MS...
Diagnosis - time matters in MS
Whilst advances in health technologies mean the ability to diagnose MS is better than ever, unfortunately MS diagnosis is often delayed.
One major reason is that many women (and men) don’t join the dots around their health niggles. Furthermore, and significantly, as MS symptoms vary so...
We Won't Let it Win!
Multiple sclerosis won’t keep us away from our sporting passions.
Multiple sclerosis is a condition of the nervous system which affects over 25,600 Aussies. Although there’s no cure, this hasn’t stopped these two inspiring women from fulfilling...
MS treatments announcements from PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) makes recommendations to the Australian Government about the medicines for subsidy through the Pharmaceutical Benefits Scheme (PBS).
Today (21 August 2020), the Pharmaceutical Benefits Advisory Committee (PBAC) made the following...
Neurological Alliance Australia (NAA) Joint Position Statement regarding Expanded Telehealth
MS organisations to ‘speak with one voice’
